Did Your GLP-1 Stop Working? Appetite, Receptors and Weight-Loss Plateaus
Summary
Host John Garrett debunks the myth that GLP-1 receptor desensitization causes weight loss plateaus on semaglutide, tirzepatide, or retatrutide. He explains that plateaus result from metabolic adaptation and energy balance shifts rather than "burned out" receptors. The episode clarifies that switching drugs or taking breaks does not reset receptors, urging listeners to evaluate lifestyle factors and clinical data instead of relying on online theories.
Topics discussed
Sponsored segments: LinkedIn Hiring Pro and Gatorade
The myth of GLP-1 receptor desensitization and plateaus
Episode intro: Peptides Explained with John Garrett
Biology of GLP-1 receptors: Internalization vs. burnout
Metabolic adaptation and why weight loss slows down
Tachyphylaxis and gastric emptying effects
Semaglutide data: Sustained weight loss and curve flattening
Terzepatide vs. Semaglutide: Switching drugs explained
Retrotutide: Investigational data and appetite suppression
The 'receptor reset' theory and drug holidays
Real-world user reports and anecdotal evidence
How to clinically evaluate a weight loss plateau
Safety warnings and FDA approval status distinctions
Conclusion: Distinguishing biology from clinical outcomes
Sponsored segments: Nesquik and Uber Eats
Listen ad-free on Castria